Report Content
Chapter 1 Methodology & Scope
1.1 Market definitions
1.2 Base estimates & working
1.2.1 North America
1.2.2 Europe
1.2.3 Asia Pacific
1.2.4 Latin America
1.2.5 Middle East & Africa
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Public sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Blood group typing industry 3600 synopsis, 2017 - 2030
2.1.1 Business trends
2.1.2 Components trends
2.1.3 Technique trends
2.1.4 Test type trends
2.1.5 End-use trends
2.1.6 Regional trends
Chapter 3 Blood Group Typing Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2017 - 2030
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Growing number of road accidents, emergenices and trauma cases necessitating blood transfusion
3.3.1.2 Several blood donation campaigns undertaken by various organization
3.3.1.3 Increasing demand for blood group typing in prenatal testing
3.3.2 Industry pitfalls & challenges
3.3.2.1 Increasing prevalence of Transfusion Transmitted Infections (TTIs)
3.4 Growth potential analysis
3.4.1 By components
3.4.2 By technique
3.4.3 By test type
3.4.4 By end-use
3.5 COVID- 19 impact analysis
3.6 Regulatory landscape
3.6.1 North America
3.6.2 Europe
3.6.3 Asia Pacific
3.7 Technology landscape
3.8 Blood type compatibility landscape
3.9 Porter's analysis
3.9.1 Bargaining power of suppliers
3.9.2 Bargaining power of buyers
3.9.3 Threat of new entrants
3.9.4 Threat of substitutes
3.10 Competitive landscape, 2021
3.10.1 Global company market share analysis, 2021
3.10.2 Company matrix analysis, 2021
3.11 PESTLE analysis
3.11.1 Political
3.11.2 Economic
3.11.3 Social
3.11.4 Technological
3.11.5 Environmental
3.11.6 Legal
Chapter 4 Blood Group Typing Market, By Components
4.1 Key segment trends
4.2 Consumables
4.2.1 Market size, by region, 2017 - 2030 (USD Million)
4.3 Instruments
4.3.1 Market size, by region, 2017 - 2030 (USD Million)
4.4 Services
4.4.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 5 Blood Group Typing Market, By Technique
5.1 Key segment trends
5.2 PCR-based & Microarray
5.2.1 Market size, by region, 2017 - 2030 (USD Million)
5.3 Assay-based
5.3.1 Market size, by region, 2017 - 2030 (USD Million)
5.4 Next Generation Sequencing (NGS)
5.4.1 Market size, by region, 2017 - 2030 (USD Million)
5.5 Other
5.5.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 6 Blood Group Typing Market, By Test Type
6.1 Key segment trends
6.2 Antigen typing
6.2.1 Market size, by region, 2017 - 2030 (USD Million)
6.3 Anitbody screening & identification
6.3.1 Market size, by region, 2017 - 2030 (USD Million)
6.4 ABO Tests
6.4.1 Market size, by region, 2017 - 2030 (USD Million)
6.5 Cross-matching Tests
6.5.1 Market size, by region, 2017 - 2030 (USD Million)
6.6 Other
6.6.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 7 Blood Group Typing Market, By End-use
7.1 Key segment trends
7.2 Hospitals
7.2.1 Market size, by region, 2017 - 2030 (USD Million)
7.3 Laboratories
7.3.1 Market size, by region, 2017 - 2030 (USD Million)
7.4 Blood banks
7.4.1 Market size, by region, 2017 - 2030 (USD Million)
7.5 Others
7.5.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 8 Blood Group Typing Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 Market size, by country, 2017 - 2030 (USD Million)
8.2.2 Market size, by components, 2017 - 2030 (USD Million)
8.2.3 Market size, by technique, 2017 - 2030 (USD Million)
8.2.4 Market size, by test type, 2017 - 2030 (USD Million)
8.2.5 Market size, by end-use, 2017 - 2030 (USD Million)
8.2.6 U.S.
8.2.6.1 Market size, by components, 2017 - 2030 (USD Million)
8.2.6.2 Market size, by technique, 2017 - 2030 (USD Million)
8.2.6.3 Market size, by test type, 2017 - 2030 (USD Million)
8.2.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
8.2.7 Canada
8.2.7.1 Market size, by components, 2017 - 2030 (USD Million)
8.2.7.2 Market size, by technique, 2017 - 2030 (USD Million)
8.2.7.3 Market size, by test type, 2017 - 2030 (USD Million)
8.2.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
8.3 Europe
8.3.1 Market size, by country, 2017 - 2030 (USD Million)
8.3.2 Market size, by components, 2017 - 2030 (USD Million)
8.3.3 Market size, by technique, 2017 - 2030 (USD Million)
8.3.4 Market size, by test type, 2017 - 2030 (USD Million)
8.3.5 Market size, by end-use, 2017 - 2030 (USD Million)
8.3.6 Germany
8.3.6.1 Market size, by components, 2017 - 2030 (USD Million)
8.3.6.2 Market size, by components, 2017 - 2030 (USD Million)
8.3.6.3 Market size, by test type, 2017 - 2030 (USD Million)
8.3.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
8.3.7 UK
8.3.7.1 Market size, by components, 2017 - 2030 (USD Million)
8.3.7.2 Market size, by technique, 2017 - 2030 (USD Million)
8.3.7.3 Market size, by test type, 2017 - 2030 (USD Million)
8.3.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
8.3.8 France
8.3.8.1 Market size, by components, 2017 - 2030 (USD Million)
8.3.8.2 Market size, by technique, 2017 - 2030 (USD Million)
8.3.8.3 Market size, by test type, 2017 - 2030 (USD Million)
8.3.8.4 Market size, by end-use, 2017 - 2030 (USD Million)
8.3.9 Spain
8.3.9.1 Market size, by components, 2017 - 2030 (USD Million)
8.3.9.2 Market size, by technique, 2017 - 2030 (USD Million)
8.3.9.3 Market size, by test type, 2017 - 2030 (USD Million)
8.3.9.4 Market size, by end-use, 2017 - 2030 (USD Million)
8.3.10 Italy
8.3.10.1 Market size, by components, 2017 - 2030 (USD Million)
8.3.10.2 Market size, by technique, 2017 - 2030 (USD Million)
8.3.10.3 Market size, by test type, 2017 - 2030 (USD Million)
8.3.10.4 Market size, by end-use, 2017 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Market size, by country, 2017 - 2030 (USD Million)
8.4.2 Market size, by components, 2017 - 2030 (USD Million)
8.4.3 Market size, by technique, 2017 - 2030 (USD Million)
8.4.4 Market size, by test type, 2017 - 2030 (USD Million)
8.4.5 Market size, by end-use, 2017 - 2030 (USD Million)
8.4.6 Japan
8.4.6.1 Market size, by components, 2017 - 2030 (USD Million)
8.4.6.2 Market size, by technique, 2017 - 2030 (USD Million)
8.4.6.3 Market size, by test type, 2017 - 2030 (USD Million)
8.4.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
8.4.7 China
8.4.7.1 Market size, by components, 2017 - 2030 (USD Million)
8.4.7.2 Market size, by technique, 2017 - 2030 (USD Million)
8.4.7.3 Market size, by test type, 2017 - 2030 (USD Million)
8.4.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
8.4.8 India
8.4.8.1 Market size, by components, 2017 - 2030 (USD Million)
8.4.8.2 Market size, by technique, 2017 - 2030 (USD Million)
8.4.8.3 Market size, by test type, 2017 - 2030 (USD Million)
8.4.8.4 Market size, by end-use, 2017 - 2030 (USD Million)
8.4.9 Australia
8.4.9.1 Market size, by components, 2017 - 2030 (USD Million)
8.4.9.2 Market size, by technique, 2017 - 2030 (USD Million)
8.4.9.3 Market size, by test type, 2017 - 2030 (USD Million)
8.4.9.4 Market size, by end-use, 2017 - 2030 (USD Million)
8.5 Latin America
8.5.1 Market size, by country, 2017 - 2030 (USD Million)
8.5.2 Market size, by components, 2017 - 2030 (USD Million)
8.5.3 Market size, by technique, 2017 - 2030 (USD Million)
8.5.4 Market size, by test type, 2017 - 2030 (USD Million)
8.5.5 Market size, by end-use, 2017 - 2030 (USD Million)
8.5.6 Brazil
8.5.6.1 Market size, by components, 2017 - 2030 (USD Million)
8.5.6.2 Market size, by technique, 2017 - 2030 (USD Million)
8.5.6.3 Market size, by test type, 2017 - 2030 (USD Million)
8.5.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
8.5.7 Mexico
8.5.7.1 Market size, by components, 2017 - 2030 (USD Million)
8.5.7.2 Market size, by technique, 2017 - 2030 (USD Million)
8.5.7.3 Market size, by test type, 2017 - 2030 (USD Million)
8.5.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
8.6 Middle East and Africa
8.6.1 Market size, by country, 2017 - 2030 (USD Million)
8.6.2 Market size, by components, 2017 - 2030 (USD Million)
8.6.3 Market size, by technique, 2017 - 2030 (USD Million)
8.6.4 Market size, by test type, 2017 - 2030 (USD Million)
8.6.5 Market size, by end-use, 2017 - 2030 (USD Million)
8.6.6 South Africa
8.6.6.1 Market size, by components, 2017 - 2030 (USD Million)
8.6.6.2 Market size, by technique, 2017 - 2030 (USD Million)
8.6.6.3 Market size, by test type, 2017 - 2030 (USD Million)
8.6.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
8.6.7 Saudi Arabia
8.6.7.1 Market size, by components, 2017 - 2030 (USD Million)
8.6.7.2 Market size, by technique, 2017 - 2030 (USD Million)
8.6.7.3 Market size, by test type, 2017 - 2030 (USD Million)
8.6.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
Chapter 9 Company Profiles
9.1 Competitive dashboard, 2021
9.2 Grifols
9.2.1 Business Overview
9.2.2 Financial Data
9.2.3 Product Landscape
9.2.4 Strategic Outlook
9.2.5 SWOT Analysis
9.3 Ortho Clinical Diagnostics
9.3.1 Business Overview
9.3.2 Financial Data
9.3.3 Product Landscape
9.3.4 Strategic Outlook
9.3.5 SWOT Analysis
9.4 Immucor
9.4.1 Business Overview
9.4.2 Financial Data
9.4.3 Product Landscape
9.4.4 Strategic Outlook
9.4.5 SWOT Analysis
9.5 Quotient
9.5.1 Business Overview
9.5.2 Financial Data
9.5.3 Product Landscape
9.5.4 Strategic Outlook
9.5.5 SWOT Analysis
9.6 BAG GROUP DIAGNOSTICS
9.6.1 Business Overview
9.6.2 Financial Data
9.6.3 Product Landscape
9.6.4 Strategic Outlook
9.6.5 SWOT Analysis
9.7 Bio-Rad Laboratories
9.7.1 Business Overview
9.7.2 Financial Data
9.7.3 Product Landscape
9.7.4 Strategic Outlook
9.7.5 SWOT Analysis
9.8 Agena Biosciences Inc
9.8.1 Business Overview
9.8.2 Financial Data
9.8.3 Product Landscape
9.8.4 Strategic Outlook
9.8.5 SWOT Analysis
9.9 Thermo Fisher Scientific (One Lambda, Inc)
9.9.1 Business Overview
9.9.2 Financial Data
9.9.3 Product Landscape
9.9.4 Strategic Outlook
9.9.5 SWOT Analysis
9.10 Danaher (Beckman Coulter)
9.10.1 Business Overview
9.10.2 Financial Data
9.10.3 Product Landscape
9.10.4 Strategic Outlook
9.10.5 SWOT Analysis
9.11 Rapid Labs Ltd
9.11.1 Business Overview
9.11.2 Financial Data
9.11.3 Product Landscape
9.11.4 Strategic Outlook
9.11.5 SWOT Analysis
